Telaprevir Patent Expiration
Telaprevir is Used for treating chronic hepatitis C. It was first introduced by Vertex Pharmaceuticals Inc
Telaprevir Patents
Given below is the list of patents protecting Telaprevir, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Incivek | US8431615 | Dose forms | May 30, 2028 | Vertex Pharms |
| Incivek | US7820671 | Peptidomimetic protease inhibitors | Feb 25, 2025 | Vertex Pharms |
| Incivek | US8529882 | Peptidomimetic protease inhibitors |
Aug 31, 2021
(Expired) | Vertex Pharms |
Telaprevir's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List